Related Experiment Video
Updated: Feb 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Racial/ethnic differences in treatment recommendations: lifestyle changes and medication prescriptions for high
1Department of Sociology and Population Program, Institute of Behavioral Science, University of Colorado Boulder, Boulder, CO, USA.
Insights
Racial and ethnic disparities exist in high cholesterol treatment. Non-Hispanic Black and Hispanic patients received more lifestyle change advice, but fewer medication prescriptions, indicating potential discrimination.
Area of Science:
- Cardiovascular Disease
- Health Disparities
- Medical Treatment
Background:
- High cholesterol affects nearly one third of US adults and is a precursor to coronary heart disease.
- Understanding race/ethnic differences in treatment is crucial for equitable care.
Purpose of the Study:
- To investigate race/ethnic disparities in treatment recommendations for high cholesterol.
- Examined differences in lifestyle change advice and prescription medication.
Main Methods:
- Utilized data from the National Health and Nutrition Examination Survey (NHANES) and National Ambulatory Medical Care Survey (NAMCS).
- Employed logistic regression analyses, adjusting for demographic, socioeconomic, and health-related factors.
- Analyzed treatment recommendations by patient race/ethnicity and age.
Main Results:
- Non-Hispanic Black and Hispanic patients were more likely to receive lifestyle change recommendations than non-Hispanic White patients.
- These disparities were more pronounced in younger adults and diminished in those over 65.
- Non-Hispanic Black patients received fewer cholesterol-lowering medication prescriptions compared to non-Hispanic White patients, especially younger individuals.
Conclusions:
- Significant race/ethnic differences exist in high cholesterol treatment recommendations.
- Disparities in lifestyle advice, not prescription practices, may indicate discrimination.
- Increased provider education on effective treatment is recommended to address these inequities.
Abstract:
Objective: High cholesterol is a common condition in the United States, affecting nearly one third of adults, and is a leading precursor to coronary heart disease. This study investigates race/ethnic differences in treatment recommendations for patients with high cholesterol, including prescription medication and lifestyle changes such as eating less fat, losing weight, or exercising more.Design: Data were obtained from the 2005 to 2010 National Health and Nutrition Examination Survey (N = 4846), a representative sample of adults in the United States, and the 2005-2010 National Ambulatory Medical Care Survey (N = 12,113), a representative sample of patient visits in the United States. Logistic regression analyses were used to assess whether health professionals recommended lifestyle changes or medication prescriptions differently by patient race/ethnicity and age. Models adjusted for demographic characteristics, socioeconomic status, health behaviors, health care access/utilization, and comorbidities.Results: Non-Hispanic Black and Hispanic patients with high cholesterol were significantly and substantially more likely to receive recommendations for lifestyle changes compared to non-Hispanic White patients. These differences were exacerbated at younger ages and largely diminished for adults over the age of 65. These patterns were reflected in both datasets. However, non-Hispanic Black patients from the NHANES analysis were less likely than non-Hispanic White patients to receive medication prescriptions for high cholesterol, particularly at younger ages. There were no race/ethnic differences in odds of medication prescriptions for Hispanic patients compared to White patients.Conclusions: Results suggest widespread and pervasive race/ethnic differences in recommending lifestyle changes for patients with high cholesterol. Although lifestyle changes may lower cholesterol they are often less effective than prescription medication. Because differences in lifestyle recommendations were not reflected in prescription practices, results may indicate a form of discrimination within physician-patient interactions that could be addressed by increased provider education about most effective treatment practices.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Hypertension IV: Drug Therapy and Lifestyle Modifications
Cholesterol: Significance and Regulation
Considering cholesterol and...
Angina IV: Management

